GB1510071A - Assay method for paracetamol - Google Patents

Assay method for paracetamol

Info

Publication number
GB1510071A
GB1510071A GB4489/76A GB448976A GB1510071A GB 1510071 A GB1510071 A GB 1510071A GB 4489/76 A GB4489/76 A GB 4489/76A GB 448976 A GB448976 A GB 448976A GB 1510071 A GB1510071 A GB 1510071A
Authority
GB
United Kingdom
Prior art keywords
paracetamol
assay method
deproteinized
feb
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4489/76A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham SWG Ltd
Original Assignee
Sterling Winthrop Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Group Ltd filed Critical Sterling Winthrop Group Ltd
Priority to GB4489/76A priority Critical patent/GB1510071A/en
Priority to LU76701A priority patent/LU76701A1/xx
Priority to DE19772704194 priority patent/DE2704194A1/en
Priority to NL7701133A priority patent/NL7701133A/en
Priority to FI770380A priority patent/FI770380A/fi
Priority to NO770373A priority patent/NO770373L/en
Priority to DK47577A priority patent/DK47577A/en
Priority to SE7701266A priority patent/SE7701266L/en
Priority to BE174681A priority patent/BE851110A/en
Priority to FR7703365A priority patent/FR2340550A1/en
Publication of GB1510071A publication Critical patent/GB1510071A/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

1510071 Paracetamol determination STERLING WINTHROP GROUP Ltd 4 Feb 1977 [5 Feb 1976] 04489/76 Heading G1B In an assay method for paracetamol in blood, a blood sample is deproteinized and the deproteinized layer of liquid separated off, reacted with excess nitrous acid and made alkaline so that paracetamol present will give the sample a yellow colour, the intensity of which is a measure of the paracetamol concentration.
GB4489/76A 1976-02-05 1976-02-05 Assay method for paracetamol Expired GB1510071A (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB4489/76A GB1510071A (en) 1976-02-05 1976-02-05 Assay method for paracetamol
LU76701A LU76701A1 (en) 1976-02-05 1977-02-01
DE19772704194 DE2704194A1 (en) 1976-02-05 1977-02-02 METHOD FOR DETERMINATION OF PARACETAMOL IN BODY FLUIDS
NL7701133A NL7701133A (en) 1976-02-05 1977-02-03 METHOD FOR THE DETERMINATION OF PARACETAMOL IN BLOOD.
FI770380A FI770380A (en) 1976-02-05 1977-02-03
NO770373A NO770373L (en) 1976-02-05 1977-02-04 PROCEDURE FOR DETERMINING PARACETAMOL.
DK47577A DK47577A (en) 1976-02-05 1977-02-04 PROCEDURE FOR DETERMINATION OF PARACETAMOL IN BLOOD
SE7701266A SE7701266L (en) 1976-02-05 1977-02-04 PROCEDURE FOR DETERMINATION OF PARACETAMOL
BE174681A BE851110A (en) 1976-02-05 1977-02-04 TITRATION OF PARACETAMOL IN BODY FLUIDS
FR7703365A FR2340550A1 (en) 1976-02-05 1977-02-07 PARACETAMOL TITRATION PROCESS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4489/76A GB1510071A (en) 1976-02-05 1976-02-05 Assay method for paracetamol

Publications (1)

Publication Number Publication Date
GB1510071A true GB1510071A (en) 1978-05-10

Family

ID=9778144

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4489/76A Expired GB1510071A (en) 1976-02-05 1976-02-05 Assay method for paracetamol

Country Status (10)

Country Link
BE (1) BE851110A (en)
DE (1) DE2704194A1 (en)
DK (1) DK47577A (en)
FI (1) FI770380A (en)
FR (1) FR2340550A1 (en)
GB (1) GB1510071A (en)
LU (1) LU76701A1 (en)
NL (1) NL7701133A (en)
NO (1) NO770373L (en)
SE (1) SE7701266L (en)

Also Published As

Publication number Publication date
FR2340550A1 (en) 1977-09-02
DE2704194A1 (en) 1977-08-11
NL7701133A (en) 1977-08-09
SE7701266L (en) 1977-09-16
FI770380A (en) 1977-08-06
BE851110A (en) 1977-05-31
NO770373L (en) 1977-08-08
DK47577A (en) 1977-08-06
LU76701A1 (en) 1977-06-28

Similar Documents

Publication Publication Date Title
DK0431456T3 (en) Use of a heavy-soluble salt of a heteropoly acid for the determination of an analyte, similar method for the determination and suitable agent for this
ES550288A0 (en) PROCEDURE TO IMPROVE THE COLORIMETRIC DEH2 O2 DETERMINATION
EP0212489A3 (en) Anabolic activity modulator and uses thereof
JPS52150692A (en) Activity measuring method of substrate or enzyme and reagent for carrying out the method
JPS5286392A (en) Method and reagent of determination of h2o2 forming substances by oxygen through the agency of oxidase in serum
SE8300320L (en) APPLICATION OF A SALT SOLUTION OF MONOCLONAL ANTIBODIES WITH RELATIVE HIGH SALT CONTENT IN BLOOD GROUP DETERMINATION
JPS6418059A (en) Analysis method and element for protein analysis
DE3675951D1 (en) TESTING OF SUBSTANCES WITH ULTRASOUND.
IT7823200A0 (en) PROCESS AND REAGENT FOR THE DETERMINATION OF ASCORBIC ACID.
JPS5350323A (en) Production of antiserum and quantitative analysis of protein by said antiserum
GB1510071A (en) Assay method for paracetamol
JPS5292773A (en) Automatic analyzer
DE3587542D1 (en) Methods for in vitro diagnosis of human cytomegalovirus infections and use of monoclonal antibodies against cytomegaloviruses which react with a cytomegalovirus-induced protein kinase.
SE437303B (en) PROCEDURE FOR ON-LINE Saturation of the concentration of an analyte in a container, as well as apparatus for performing the procedure
DE3584661D1 (en) IN VITRO TESTING PROCEDURE FOR DETERMINING EYE PROPERTIES.
IL60549A0 (en) Method of blood typing and antibody reagent for use therein
ES454866A1 (en) Method for measuring antistreptolysin concentration in blood
ES2056872T3 (en) ANTICOAGULANT PROTEIN PP4-X, ITS PREPARATION AND USE.
IT7821633A0 (en) PROCESS AND REAGENT FOR THE DETERMINATION OF URIC ACID.
SU605608A1 (en) Method of studying branches of main blood vessels
ES8200097A1 (en) Manufacture of urea derivative
JPS5386014A (en) Quantitative analysis of antigen and antibody
GB1369582A (en) Specific antiserum and method for radioimmunoassay of human chorionic gonadotropin
JPS51144293A (en) Continuous analysis system of urine, etc
SU1090719A1 (en) Method for determining in vitro threshold concentration of membranetoxic effect of chemicals

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee